Abstract

BackgroundDevil Facial Tumour Disease (DFTD) is a unique clonal cancer that threatens the world's largest carnivorous marsupial, the Tasmanian devil (Sarcophilus harrisii) with extinction. This transmissible cancer is passed between individual devils by cell implantation during social interactions. The tumour arose in a Schwann cell of a single devil over 15 years ago and since then has expanded clonally, without showing signs of replicative senescence; in stark contrast to a somatic cell that displays a finite capacity for replication, known as the “Hayflick limit”.Methodology/Principal FindingsIn the present study we investigate the role of telomere length, measured as Telomere Copy Number (TCN), and telomerase and shelterin gene expression, as well as telomerase activity in maintaining hyperproliferation of Devil Facial Tumour (DFT) cells. Our results show that DFT cells have short telomeres. DFTD TCN does not differ between geographic regions or between strains. However, TCN has increased over time. Unlimited cell proliferation is likely to have been achieved through the observed up-regulation of the catalytic subunit of telomerase (TERT) and concomitant activation of telomerase. Up-regulation of the central component of shelterin, the TRF1-intercating nuclear factor 2 (TINF2) provides DFT a mechanism for telomere length homeostasis. The higher expression of both TERT and TINF2 may also protect DFT cells from genomic instability and enhance tumour proliferation.Conclusions/SignificanceDFT cells appear to monitor and regulate the length of individual telomeres: i.e. shorter telomeres are elongated by up-regulation of telomerase-related genes; longer telomeres are protected from further elongation by members of the shelterin complex, which may explain the lack of spatial and strain variation in DFT telomere copy number. The observed longitudinal increase in gene expression in DFT tissue samples and telomerase activity in DFT cell lines might indicate a selection for more stable tumours with higher proliferative potential.

Highlights

  • The world’s largest carnivorous marsupial, the Tasmanian devil (Sarcophilus harrisii) has recently become threatened with extinction due to a unique transmissible cancer, Devil Facial Tumour Disease (DFTD) [1,2,3]

  • TERT gene expression is up-regulated 15-fold in DFT cells compared to spleen cells, and telomerase activity is present in DFT cell lines

  • High expression of TRF1-intercating nuclear factor 2 (TINF2), a negative regulator of telomerase activity [23], in DFT cells suggests that telomere elongation is highly regulated in this cancer

Read more

Summary

Introduction

The world’s largest carnivorous marsupial, the Tasmanian devil (Sarcophilus harrisii) has recently become threatened with extinction due to a unique transmissible cancer, Devil Facial Tumour Disease (DFTD) [1,2,3]. Increased knowledge of telomere homeostasis in this transmissible cancer may provide novel insights into how DFT cells achieve and maintain their hyperproliferative potential and may help us to understand the origins, somatic evolution and extraordinary success of this parasitic clonal lineage. Both TERT and TINF2 have been suggested as potential therapeutic targets in human cancer [32,33] and increasing our understanding of the role of these genes in Devil Facial Tumour Disease may open novel avenues for disease treatment. Temporal changes in telomerase activity were quantified in five DFT cell lines

Results
Discussion
Findings
Materials and Methods

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.